
zzso zzso is an orally available zzso analog with zzso activity that results from the zzso of DNA zzso zzso Previous studies have suggested that it has significant clinical zzso The primary zzso of zzso include gastrointestinal upset, zzso and zzso at the maximum tolerated dose zzso of zzso zzso per zzso zzso is a zzso of zzso that is approved for use in patients with zzso breast zzso and zzso zzso and it offers the convenience of oral zzso This trial examined the combination of these two oral agents in patients with zzso solid zzso 

zzso was administered twice daily at a total daily dose of zzso zzso per day for 14 days followed by a zzso zzso zzso was taken daily 5 days per week for 2 weeks in a zzso zzso The starting dose was zzso zzso per day, and zzso of 3 patients were enrolled until the dose level reached zzso zzso per zzso 

zzso patients were zzso for toxicity and response, and zzso and zzso were the zzso zzso Despite zzso prophylaxis with zzso antagonists, 2 of 3 patients at the zzso zzso per day dose level had Grade 2-3 zzso while at the zzso of zzso zzso per day, 3 of 14 patients had Grade zzso or zzso 2 zzso The zzso of zzso syndrome, zzso zzso and zzso did not exceed that expected with zzso alone, suggesting that zzso does not exacerbate these side zzso No objective responses were zzso zzso disease was observed in 9 patients zzso with a median duration of 11 weeks, including 3 patients with responses that lasted from 20 weeks to 40 zzso 

The combination of zzso and zzso with the current schedule was limited in dose by zzso and had minimal clinical efficacy in a group of patients with zzso solid zzso 

